Re: Trial design Faulty
|
8
|
Resverlogix Corp.
|
Oct 01, 2019 02:00PM
|
Re: Demoralizing....
|
8
|
Resverlogix Corp.
|
Sep 21, 2017 06:23PM
|
Re: So.....?
|
8
|
Resverlogix Corp.
|
Oct 14, 2017 08:24AM
|
Re: https://scr.zacks.co...
|
8
|
Zenith Epigenetics
|
May 06, 2020 08:51AM
|
Re: ZHCLF
|
8
|
Zenith Epigenetics
|
Feb 11, 2024 07:57AM
|
Re: SP 884+ Week Low.
|
7
|
Resverlogix Corp.
|
Oct 17, 2022 07:17PM
|
Re: Shorts
|
7
|
Resverlogix Corp.
|
Feb 12, 2024 09:41AM
|
Re: My New Year's wish if for RVX to get a deal structured similarly to MYOV...
|
7
|
Resverlogix Corp.
|
Dec 29, 2020 07:31PM
|
Re: December 22, 2020.
|
7
|
Resverlogix Corp.
|
Oct 10, 2020 12:59PM
|
Re: Zenith Epigenetics Advances ZEN-3694 in Multiple Cancer Programs
|
7
|
Zenith Epigenetics
|
Jul 29, 2020 03:22PM
|
Re: New Apabetalone Fabry Disease Publication
|
7
|
Resverlogix Corp.
|
Apr 26, 2022 08:11PM
|
Re: Is our nice little run over?
|
7
|
Resverlogix Corp.
|
Sep 30, 2020 11:29AM
|
Re: Apabetalone......a Calculated Risk
|
7
|
Resverlogix Corp.
|
Apr 06, 2019 06:56PM
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
7
|
Resverlogix Corp.
|
Dec 22, 2020 08:19AM
|
Re: Stonegate Capital Partners Initiates Coverage on Resverlogix
|
7
|
Resverlogix Corp.
|
Nov 05, 2015 05:08PM
|
Re: Ground Hog Day
|
7
|
Resverlogix Corp.
|
Sep 18, 2020 03:46PM
|
Re: Congratulations To.....
|
7
|
Resverlogix Corp.
|
Dec 11, 2019 11:21AM
|
Re: Resverlogix Announces $13 Million Private Placement
|
7
|
Resverlogix Corp.
|
Oct 06, 2020 09:05AM
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
7
|
Resverlogix Corp.
|
Apr 11, 2018 08:45AM
|
Re: New Apabetalone Fabry Disease Publication
|
7
|
Resverlogix Corp.
|
Apr 27, 2022 06:44AM
|